Lataa...
Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators
We demonstrate that combined treatment with metformin (Met) or its mitochondria-targeted analog, mito-metformin (Mito-Met), and various iron chelators synergistically inhibits proliferation of pancreatic and triple-negative breast cancer cells. Previously, we reported that Met (at millimolar levels)...
Tallennettuna:
| Julkaisussa: | Oncotarget |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6544408/ https://ncbi.nlm.nih.gov/pubmed/31191823 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26943 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|